A Phase 1, Single-Dose, Open-Label, Crossover Study To Assess The Relative Bioavailability Of 2 Different Formulations Of PF-04991532.
Phase of Trial: Phase I
Latest Information Update: 09 Aug 2011
At a glance
- Drugs PF 4991532 (Primary)
- Indications Diabetes mellitus
- Focus Pharmacokinetics
- 09 Aug 2011 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 11 Jul 2011 New trial record